A low-cost, widely available steroid lowered mortality among critically ill COVID-19 patients by one-third in a rigorous large-scale UK trial, Esther Gillmor reports.
It’s not just documents surrounding drug shortages that are leaking, the government’s approach is also full of holes. Alex Bird explores the effects of Brexit on drug supply and how the situation will affect patients.